Home > Boards > Free Zone > Health and Sciences > Biotech Values

The market seems to think that 38% market

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 754
Posts 116,615
Boards Moderated 9
Alias Born 09/05/02
160x600 placeholder
DewDiligence Member Level  Wednesday, 12/18/13 04:36:18 PM
Re: gdollasign post# 171472
Post # of 239659 
Quote:
The market seems to think that 38% market share is too large.

That the market expects ABBV/ENTA to get less than 38% of the GT1 market is clear not only from ENTA’s valuation, but also from a survey by ISI analyst, Mark Schoenbaum of the “buy side” in which the average forecast was a 23% share for ABBV/ENTA.

Of course, such disagreements are what makes a market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences